Anti Biotic Who
Anti Biotic Who
Anti Biotic Who
Antibiotic resistance
Key facts
Antibiotic resistance is one of the biggest threats to global health, food security, and
development today.
Antibiotic resistance can affect anyone, of any age, in any country.
Antibiotic resistance occurs naturally, but misuse of antibiotics in humans and animals is
accelerating the process.
A growing number of infections – such as pneumonia, tuberculosis, gonorrhoea, and
salmonellosis – are becoming harder to treat as the antibiotics used to treat them become
less effective.
Antibiotic resistance leads to longer hospital stays, higher medical costs and increased
mortality.
Introduction
Antibiotics are medicines used to prevent and treat bacterial infections. Antibiotic resistance occurs
when bacteria change in response to the use of these medicines.
Bacteria, not humans or animals, become antibiotic-resistant. These bacteria may infect humans and
animals, and the infections they cause are harder to treat than those caused by non-resistant
bacteria.
Antibiotic resistance leads to higher medical costs, prolonged hospital stays, and increased mortality.
The world urgently needs to change the way it prescribes and uses antibiotics. Even if new medicines
are developed, without behaviour change, antibiotic resistance will remain a major threat. Behaviour
changes must also include actions to reduce the spread of infections through vaccination, hand
washing, practising safer sex, and good food hygiene.
Antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance
mechanisms are emerging and spreading globally, threatening our ability to treat common infectious
diseases. A growing list of infections – such as pneumonia, tuberculosis, blood poisoning,
gonorrhoea, and foodborne diseases – are becoming harder, and sometimes impossible, to treat as
antibiotics become less effective.
Where antibiotics can be bought for human or animal use without a prescription, the emergence and
spread of resistance is made worse. Similarly, in countries without standard treatment guidelines,
antibiotics are often over-prescribed by health workers and veterinarians and over-used by the public.
Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor
injuries can once again kill.
Antibiotic resistance is accelerated by the misuse and overuse of antibiotics, as well as poor infection
prevention and control. Steps can be taken at all levels of society to reduce the impact and limit the
spread of resistance.
Individuals
Policy makers
To prevent and control the spread of antibiotic resistance, policy makers can:
Health professionals
To prevent and control the spread of antibiotic resistance, health professionals can:
Prevent infections by ensuring your hands, instruments, and environment are clean.
Only prescribe and dispense antibiotics when they are needed, according to current guidelines.
Report antibiotic-resistant infections to surveillance teams.
Talk to your patients about how to take antibiotics correctly, antibiotic resistance and the dangers of
misuse.
Talk to your patients about preventing infections (for example, vaccination, hand washing, safer sex,
and covering nose and mouth when sneezing).
Healthcare industry
To prevent and control the spread of antibiotic resistance, the health industry can:
Invest in research and development of new antibiotics, vaccines, diagnostics and other tools.
Agriculture sector
To prevent and control the spread of antibiotic resistance, the agriculture sector can:
Recent developments
While there are some new antibiotics in development, none of them are expected to be effective
against the most dangerous forms of antibiotic-resistant bacteria.
Given the ease and frequency with which people now travel, antibiotic resistance is a global problem,
requiring efforts from all nations and many sectors.
Impact
3
When infections can no longer be treated by first-line antibiotics, more expensive medicines must be
used. A longer duration of illness and treatment, often in hospitals, increases health care costs as
well as the economic burden on families and societies.
Antibiotic resistance is putting the achievements of modern medicine at risk. Organ transplantations,
chemotherapy and surgeries such as caesarean sections become much more dangerous without
effective antibiotics for the prevention and treatment of infections.
WHO response
Tackling antibiotic resistance is a high priority for WHO. A global action plan on antimicrobial
resistance, including antibiotic resistance, was endorsed at the World Health Assembly in May 2015.
The global action plan aims to ensure prevention and treatment of infectious diseases with safe and
effective medicines.
A political declaration endorsed by Heads of State at the United Nations General Assembly in New
York in September 2016 signalled the world’s commitment to taking a broad, coordinated approach to
address the root causes of antimicrobial resistance across multiple sectors, especially human health,
animal health and agriculture. WHO is supporting Member States to develop national action plans on
antimicrobial resistance, based on the global action plan.
Held annually since 2015, WAAW is a global campaign that aims to increase awareness of
antimicrobial resistance worldwide and to encourage best practices among the general public, health
workers and policy makers to avoid the further emergence and spread of drug-resistant infections.
Antimicrobials are critical tools in helping to fight diseases in humans, animals and plants. They
include antibiotics, antivirals, antifungals and antiprotozoa. WAAW takes place every year from 18 to
24 November. The slogan has previously been, “Antibiotics: Handle with Care” but changed to
“Antimicrobials: Handle with Care” in 2020 to reflect the broadening scope of drug resistant infections.
The WHO-supported system supports a standardized approach to the collection, analysis and sharing
of data related to antimicrobial resistance at a global level to inform decision-making, drive local,
national and regional action.
A joint initiative of WHO and Drugs for Neglected Diseases initiative (DNDi), GARDP encourages
research and development through public-private partnerships. By 2023, the partnership aims to
develop and deliver up to four new treatments, through improvement of existing antibiotics and
acceleration of the entry of new antibiotic drugs.
The United Nations Secretary-General has established IACG to improve coordination between
international organizations and to ensure effective global action against this threat to health security.
The IACG is co-chaired by the UN Deputy Secretary-General and the Director General of WHO and
4
comprises high level representatives of relevant UN agencies, other international organizations, and
individual experts across different sectors.